Transgene Biotek bulk deals and stake changes
BSE: 526139Healthcare ServicesSmall Cap
Last close ₹2.57up ₹0.20 (8.44%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹2.37.
52-week range of traded prices to 23 Oct 2026
₹1.83Low, 4 Feb 2026₹4.34High, 23 Oct 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹19 Cr4,238th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 2.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- −17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- −2.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 2.05
- Volume, BSEVolume. Shares traded on the last trading day.
- 26,565
Transgene Biotek stake sales and purchases
All 6 disclosures on record.
Jun 2013
- AcquiredGeetanjali Investments5.32% of the company35,01,333 sharesholds 5.32% after18 Jun 2013 · filed under the 5% rule · Market
- SoldLeman Diversified Fund2.43% of the company15,99,535 sharesholds 3.11% after17 Jun 2013 · filed under the 2% rule · Market
- SoldSparrow Asia Diversified Opportunities Fund2.78% of the company18,27,058 sharesholds 3.08% after17 Jun 2013 · filed under the 2% rule · Market
May 2013
- SoldLeman Diversified Fund2.11% of the company13,87,434 sharesholds 5.54% after17 May 2013 · filed under the 2% rule · Market
Apr 2013
- SoldSparrow Asia Diversified Opportunities Fund2.01% of the company13,25,000 sharesholds 5.86% after12 Apr 2013 · filed under the 2% rule · Market
Nov 2008
- AcquiredK KOTESWARA RAO4.99% of the company7,50,000 sharesholds 34.90% after3 Nov 2008
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Transgene Biotek bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 1 Dec 20233 firms · ₹0.62 Cr bought · ₹0.73 Cr soldNet sold ₹0.11 Cr
- SoldGEETANJALI INVESTMENTSSold 8,96,281 at ₹8.161.18% of the company₹0.73 Cr
- BoughtMAYUR VIJAY PATWABought 4,01,000 at ₹8.190.53% of the company₹0.33 Cr
- BoughtSAHASRAR CAPITAL PRIVATE LIMITEDBought 3,71,570 at ₹7.830.49% of the company₹0.29 Cr
Friday 24 Nov 20232 firms · ₹0.32 Cr bought · ₹0.65 Cr soldNet sold ₹0.33 Cr
- SoldGEETANJALI INVESTMENTSSold 7,16,159 at ₹9.100.95% of the company₹0.65 Cr
- BoughtSAHASRAR CAPITAL PRIVATE LIMITEDBought 3,50,000 at ₹9.120.46% of the company₹0.32 Cr
Thursday 23 Nov 20231 firm · ₹0 bought · ₹0.39 Cr soldNet sold ₹0.39 Cr
- SoldGEETANJALI INVESTMENTSSold 4,47,728 at ₹8.700.59% of the company₹0.39 Cr
Thursday 27 Mar 20141 firm · ₹0.13 Cr bought · ₹0 soldNet bought ₹0.13 Cr
- BoughtSH AS ENTERPRISES LLPBought 4,00,000 at ₹3.36₹0.13 Cr
Wednesday 19 Jun 20132 firms · ₹0.56 Cr bought · ₹0 soldNet bought ₹0.56 Cr
- BoughtGEETANJALI INVESTMENTSBought 17,85,488 at ₹2.02₹0.36 Cr
- BoughtDIPESH NALINBHAI DAVEBought 10,00,000 at ₹2.03₹0.20 Cr
Tuesday 18 Jun 20131 firm · ₹0.67 Cr bought · ₹0 soldNet bought ₹0.67 Cr
- BoughtGEETANJALI INVESTMENTSBought 34,45,350 at ₹1.95₹0.67 Cr
Monday 17 Jun 20131 firm · ₹0.65 Cr bought · ₹0 soldNet bought ₹0.65 Cr
- BoughtGEETANJALI INVESTMENTSBought 35,01,333 at ₹1.85₹0.65 Cr
Wednesday 5 Jun 20131 firm · ₹0.10 Cr bought · ₹0 soldNet bought ₹0.10 Cr
- BoughtPRITI PARESH RAIMAGIYABought 5,00,297 at ₹1.96₹0.10 Cr
Tuesday 4 Jun 20131 firm · ₹0.13 Cr bought · ₹0 soldNet bought ₹0.13 Cr
- BoughtPRITI PARESH RAIMAGIYABought 6,36,310 at ₹1.97₹0.13 Cr
Monday 8 Apr 20131 firm · ₹0 bought · ₹0.07 Cr soldNet sold ₹0.07 Cr
- SoldOFFERLINK INFRAPROJECTS PRIVATELIMITEDSold 3,34,641 at ₹2.03₹0.07 Cr
Wednesday 20 Feb 20131 firm · ₹0.10 Cr bought · ₹0.10 Cr soldNet nil
- Both waysOFFERLINK INFRAPROJECTS PRIVATELIMITEDBought 3,51,336 at ₹2.80Sold 3,54,387 at ₹2.78Net −3,051 shares₹0.10 Cr bought
Wednesday 30 Jan 20131 firm · ₹0.17 Cr bought · ₹0.17 Cr soldNet nil
- Both waysOFFERLINK INFRAPROJECTS PRIVATELIMITEDBought 5,01,858 at ₹3.38Sold 5,19,038 at ₹3.25Net −17,180 shares₹0.17 Cr bought
Thursday 24 Jan 20131 firm · ₹0.15 Cr bought · ₹0.15 Cr soldNet nil
- Both waysOFFERLINK INFRAPROJECTS PRIVATELIMITEDBought 3,82,152 at ₹3.88Sold 3,91,351 at ₹3.88Net −9,199 shares₹0.15 Cr bought
Tuesday 6 Nov 20121 firm · ₹0.20 Cr bought · ₹0.22 Cr soldNet sold ₹0.02 Cr
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 3,53,085 at ₹5.73Sold 3,88,536 at ₹5.73Net −35,451 shares₹0.20 Cr bought
Friday 2 Nov 20121 firm · ₹0.39 Cr bought · ₹0.38 Cr soldNet bought ₹60,747
- Both waysSYNDICATE NIRMAN PRIVATE LIMITEDBought 6,79,658 at ₹5.72Sold 6,79,733 at ₹5.63Net −75 shares₹0.39 Cr bought
Thursday 1 Nov 20121 firm · ₹0.34 Cr bought · ₹0.36 Cr soldNet sold ₹0.02 Cr
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 5,83,337 at ₹5.91Sold 6,23,032 at ₹5.83Net −39,695 shares₹0.34 Cr bought
Monday 29 Oct 20122 firms · ₹0.88 Cr bought · ₹0.87 Cr soldNet nil
- Both waysRONAK SATISH KUMAR SHAHBought 5,10,945 at ₹7.36Sold 5,10,945 at ₹6.96Net nil₹0.38 Cr bought
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 6,81,573 at ₹7.36Sold 7,50,255 at ₹6.92Net −68,682 shares₹0.50 Cr bought
Thursday 25 Oct 20122 firms · ₹0.35 Cr bought · ₹0.40 Cr soldNet sold ₹0.05 Cr
- SoldQUANT BROKING PRIVATE LIMITEDSold 5,30,471 at ₹7.47₹0.40 Cr
- BoughtBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 4,69,874 at ₹7.46₹0.35 Cr
Thursday 18 Oct 20121 firm · ₹0.46 Cr bought · ₹0.46 Cr soldNet nil
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 4,97,076 at ₹9.35Sold 4,97,076 at ₹9.35Net nil₹0.46 Cr bought
Wednesday 17 Oct 20122 firms · ₹0.76 Cr bought · ₹1.34 Cr soldNet sold ₹0.58 Cr
- SoldPERSISTENT COMMODITIES TRADLINK PRIVATE LIMITEDSold 6,08,713 at ₹9.59₹0.58 Cr
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 8,02,093 at ₹9.50Sold 8,02,093 at ₹9.44Net nil₹0.76 Cr bought
Thursday 11 Oct 20121 firm · ₹0.42 Cr bought · ₹0.42 Cr soldNet nil
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 4,06,895 at ₹10.38Sold 4,06,895 at ₹10.43Net nil₹0.42 Cr bought
Wednesday 3 Oct 20121 firm · ₹0.40 Cr bought · ₹0.40 Cr soldNet nil
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 3,51,882 at ₹11.36Sold 3,50,734 at ₹11.33Net +1,148 shares₹0.40 Cr bought
Friday 28 Sep 20122 firms · ₹1.07 Cr bought · ₹0.49 Cr soldNet bought ₹0.58 Cr
- BoughtPERSISTENT COMMODITIES TRADLINK PRIVATE LIMITEDBought 5,21,800 at ₹10.50₹0.55 Cr
- Both waysPARK HABITATS PRIVATE LIMITEDBought 5,00,000 at ₹10.52Sold 4,32,649 at ₹11.40Net +67,351 shares₹0.53 Cr bought
Tuesday 25 Sep 20121 firm · ₹0 bought · ₹0.45 Cr soldNet sold ₹0.45 Cr
- SoldBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDSold 3,78,806 at ₹11.83₹0.45 Cr
Monday 24 Sep 20123 firms · ₹2.22 Cr bought · ₹1.97 Cr soldNet bought ₹0.25 Cr
- Both waysSYNDICATE NIRMAN PRIVATE LIMITEDBought 10,18,233 at ₹11.69Sold 8,22,446 at ₹11.50Net +1,95,787 shares₹1.19 Cr bought
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 5,16,260 at ₹11.58Sold 4,38,703 at ₹11.37Net +77,557 shares₹0.60 Cr bought
- Both waysARCADIA SHARE & STOCK BROKERS PVT. LTDBought 3,73,560 at ₹11.46Sold 4,61,235 at ₹11.37Net −87,675 shares₹0.43 Cr bought
Tuesday 18 Sep 20121 firm · ₹1.10 Cr bought · ₹1.04 Cr soldNet bought ₹0.06 Cr
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 8,08,292 at ₹13.62Sold 7,77,995 at ₹13.33Net +30,297 shares₹1.10 Cr bought
Monday 17 Sep 20122 firms · ₹1.90 Cr bought · ₹2.25 Cr soldNet sold ₹0.35 Cr
- SoldSYNDICATE NIRMAN PRIVATE LIMITEDSold 3,36,265 at ₹13.67₹0.46 Cr
- Both waysBLACKHORSEMEDIA ANDENTERTAINMENT PRIVATELIMITEDBought 13,82,350 at ₹13.71Sold 13,03,930 at ₹13.71Net +78,420 shares₹1.90 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. The latest 55 deals, on record from 4 Jan 2004.